5 months ago
ALGS
AnalystsMichael YeeMichael Yee's Stock Forecasts
AnalystsMichael Yee
Analyst Ranking
Top 14%
#584 out of 4233 analysts
Average Return
+12.66%
Win Rate
43%16 out of 37
Risk vs Reward
Poor
Good
Michael Yee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-02 - 2021-03-02 | Strong Buy |
Denali Therapeutics IncDNLI | +194.23% | $22.69 | $66.76 | 2020-02-24 - 2021-02-24 | Strong Buy |
Kodiak Sciences IncKOD | +117.10% | $67.67 | $146.91 | 2020-01-03 - 2020-12-31 | Buy |
Inhibrx IncINBX | +97.29% | $17.36 | $34.25 | 2020-09-14 - 2021-09-13 | Strong Buy |
Fibrogen IncFGEN | +94.47% | $33.45 | $65.05 | 2017-07-11 - 2018-07-11 | Strong Buy |
Michael Yee Analyst Color
Get additional color on Michael Yee's coverage of popular stocks
5 months ago
MRNA
6 months ago
BIIB
7 months ago
BIIB
Michael Yee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | 1 | Hold | $200.00 | +0.65% | Downgrades | 23 days ago |
Nuvation Bio IncNUVB | 2 | Hold | $2.00 | +23.46% | Downgrades | 5 months ago |
Aligos Therapeutics IncALGS | 1 | Strong Buy | $3.00 | +165.49% | Upgrades | 5 months ago |
Amarin Corp PLCAMRN | 3 | Strong Buy | $3.00 | +156.41% | Upgrades | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 2 | Hold | $340.00 | +5.08% | Downgrades | 5 months ago |
Moderna IncMRNA | 5 | Strong Buy | $275.00 | +115.33% | Upgrades | 5 months ago |
Biogen IncBIIB | 4 | Strong Buy | $350.00 | +18.08% | Maintains | 6 months ago |
Scholar Rock Holding CorpSRRK | 1 | Hold | $28.00 | N/A | Downgrades | a year ago |
LianbioLIAN | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Ventyx Biosciences IncVTYX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Invivyd IncIVVD | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Immuneering CorpIMRX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Immunocore Holdings PLCIMCR | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 2 years ago |
Fibrogen IncFGEN | 2 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Esperion Therapeutics IncESPR | 3 | Hold | $30.00 | N/A | Downgrades | 2 years ago |
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | $30.00 | N/A | Upgrades | 2 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Schrodinger IncSDGR | 1 | Strong Buy | $75.00 | N/A | Upgrades | 3 years ago |
Inhibrx IncINBX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Alx Oncology Holdings IncALXO | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Amgen IncAMGN | 2 | Strong Buy | $300.00 | N/A | Maintains | 3 years ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 3 years ago |
Denali Therapeutics IncDNLI | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Kodiak Sciences IncKOD | 1 | Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Axon Enterprise IncAXON | 2 | Strong Buy | $3.00 | N/A | Upgrades | 4 years ago |
Urogen Pharma LtdURGN | 2 | Strong Buy | $77.00 | N/A | Assumes | 5 years ago |
Immunomedics IncIMMU | 2 | Strong Buy | $30.00 | N/A | Assumes | 5 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Odonate Therapeutics IncODTC | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Acorda Therapeutics IncACOR | 2 | Hold | $150.00 | N/A | Maintains | 6 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $18.00 | N/A | Maintains | 6 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.